MEN1309 I.v. Infusion in Pts With CD205-positive Metastatic Solid Tumors and Relapsed or Refractory NHL Ph I Study
Condition(s):Metastatic Solid Tumors; Relapsed/Refractory Non-Hodgkin LymphomaLast Updated:September 28, 2021Terminated
Hide Studies Not Open or Pending
Condition(s):Metastatic Solid Tumors; Relapsed/Refractory Non-Hodgkin LymphomaLast Updated:September 28, 2021Terminated
Condition(s):CancerLast Updated:December 2, 2014Completed
Condition(s):Advanced or Metastatic Solid TumorsLast Updated:January 10, 2024Active, not recruiting
Condition(s):Locally Advanced Unresectable or Metastatic Solid TumorsLast Updated:November 21, 2023Recruiting
Condition(s):Metastatic Solid TumorsLast Updated:August 29, 2022Completed
Condition(s):Patients With Advanced or Metastatic Solid TumorsLast Updated:February 10, 2016Unknown status
Condition(s):Locally Advanced or Metastatic Solid Tumors; Non Small Cell Lung Cancer (NSCLC); Head and Neck Squamous Cell Carcinoma (HNSCC); Esophageal Squamous Cell Carcinoma (ESCC)Last Updated:February 3, 2023Not yet recruiting
Condition(s):Locally Advanced or Metastatic Solid TumorsLast Updated:May 25, 2023Completed
Condition(s):Advanced Solid Tumor; Locally Advanced Solid Tumor; Metastatic Solid Tumor; Head and Neck Squamous Cell Carcinoma HNSCC; HPV-associated Cancers; Neoadjuvant Melanoma; Neoadjuvant Cutaneous Squamous Cell Carcinoma (cSCC)Last Updated:March 5, 2024Recruiting
Condition(s):Advanced/Metastatic Solid Tumors or LymphomasLast Updated:December 30, 2021Terminated
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.